Regulatory News
Wednesday, January 4, 2017
BRIEF-Ocular Therapeutix announces results for Phase 3 clinical trial of DEXTENZA
* Ocular therapeutix(tm) announces additional successful
results for Phase 3 clinical trial of dextenza(tm)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment